UBD901

首页 > 组织芯片 > 尿道膀胱 > UBD901

类型
- 冰冻组织
- 石蜡组织
种类
器官
- 乳腺
- 卵巢
- 口腔
- 外阴
- 多器官
- 大鼠
- 头颈部
- 子宫
- 子宫内膜
- 小鼠
- 心脏
- 恶性黑色素瘤
- 狗
- 猴子-恒河猴（正常）-RsFPT
- 猴子-食蟹猴（正常）-CyFPT
- 皮肤
- 直肠
- 睾丸
- 结肠
- 肝脏
- 肠道
- 肺
- 肾上腺
- 肾脏
- 胃
- 胆囊和胆管
- 胎儿
- 胰腺
- 胸腺
- 脾脏
- 膀胱
- 软组织
- 输卵管
- 阑尾
- 阴茎
- 食管胃交界处
- 食道
- 骨_软骨
- 骨髓
类型/疾病
例数
- 小于25
- 26~70
- 71~100
- 101~200
- 201~300
- 大于301
点数
- 小于25
- 26~70
- 71~100
- 101~200
- 201~300
- 大于301

点数:

90

例数:

90

点样直径（mm）:

2

厚度（µm）:

5

行数:

9

列数:

10

组织阵列类型:

FFPE

种属:

Human

UBD901

加入收藏

描述: 不同分期膀胱癌组织芯片，附TNM和临床分期，90例/90点

详情: 不同分期膀胱癌组织微阵列芯片，包含61例尿路上皮癌，13例鳞状细胞癌，14例腺癌，2例小细胞癌（其中I期10例，II期25例，III期55例），一例一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

说明书列表
重复病例
下载说明书

图表:

Bladder

Malignant(I)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
_ma

组织芯片
UBD901

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

UBD901

年龄:
性别:
器官/解剖部位:
病理诊断:
等级:
分期:
阶段:
组织ID.:
类型:

POS	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size
A1	1	45	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	321.5
A2	2	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	552.5
A3	3	42	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	433
A4	4	50	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	532
A5	5	70	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	544
A6	6	82	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	332.5
A7	7	45	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
A8	8	78	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	752
A9	9	65	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	321
A10	10	77	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	21.51
B1	11	25	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	13108
B2	12	79	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	1051.5
B3	13	71	M	Bladder	Low-grade urothelial carcinoma	*	T2bN0M0	II	Malignant	4.532
B4	14	56	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	650.5
B5	15	43	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
B6	16	66	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	332
B7	17	58	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
B8	18	70	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	52.52.5
B9	19	50	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
B10	20	82	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
C1	21	61	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
C2	22	56	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321
C3	23	42	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	554
C4	24	74	F	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
C5	25	55	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321.5
C6	26	70	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
C7	27	37	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
C8	28	67	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	433
C9	29	42	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321
C10	30	70	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	543
D1	31	70	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	653
D2	32	35	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
D3	33	48	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
D4	34	69	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	2.52.52.5
D5	35	72	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
D6	36	55	M	Bladder	Low-grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
D7	37	72	M	Bladder	Low-grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	432
D8	38	45	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	1077
D9	39	56	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
D10	40	60	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	5
E1	41	74	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
E2	42	57	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	644
E3	43	67	M	Bladder	High grade urothelial carcinoma (interstitial)	*	T3N0M0	IIIA	Malignant	743
E4	44	67	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
E5	45	54	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	3.53.01
E6	46	65	F	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	432
E7	47	60	M	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	322
E8	48	70	F	Bladder	High grade urothelial carcinoma	*	T3aM0N0	IIIA	Malignant	*
E9	49	72	M	Bladder	High grade urothelial carcinoma	*	T3aN0M0	IIIA	Malignant	12125
E10	50	71	M	Bladder	High grade urothelial carcinoma with necrosis (sparse)	*	T3bN0M0	IIIA	Malignant	8*7
F1	51	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
F2	52	60	F	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	322
F3	53	45	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
F4	54	53	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	542
F5	55	53	M	Bladder	Urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	1184
F6	56	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
F7	57	33	M	Bladder	High grade urothelial carcinoma	*	T3N1M0	IIIA	Malignant	*
F8	58	53	M	Bladder	High grade urothelial carcinoma	*	T3N1M0	IIIA	Malignant	*
F9	59	40	F	Bladder	High grade urothelial carcinoma	*	T3N1M0	IIIA	Malignant	*
F10	60	52	M	Bladder	High grade urothelial carcinoma	*	T4aN0M0	IIIA	Malignant	*
G1	61	55	M	Bladder	High grade urothelial carcinoma	*	T4N0M0	IIIA	Malignant	643
G2	62	75	M	Bladder	Squamous cell carcinoma	*	T2N1M0	IIIA	Malignant	*
G3	63	51	M	Bladder	Squamous cell carcinoma	*	T3aM0N0	IIIA	Malignant	*
G4	64	68	M	Bladder	Squamous cell carcinoma	2	T3aN0M0	IIIA	Malignant	63.53
G5	65	67	M	Bladder	Squamous cell carcinoma	2	T3aN0M0	IIIA	Malignant	443.5
G6	66	68	M	Bladder	Squamous cell carcinoma	2	T3bN0M0	IIIA	Malignant	6*5.5
G7	67	46	F	Bladder	Squamous cell carcinoma	2	T3N0M0	IIIA	Malignant	*
G8	68	66	F	Bladder	Squamous cell carcinoma	2	T3N1M0	IIIA	Malignant	*
G9	69	51	M	Bladder	Squamous cell carcinoma	2	T2bN2M0	IIIB	Malignant	*
G10	70	72	M	Bladder	Squamous cell carcinoma	2--3	T3bN0M0	IIIA	Malignant	643
H1	71	57	M	Bladder	Squamous cell carcinoma	3	T3aN0M0	IIIA	Malignant	*
H2	72	52	M	Bladder	Squamous cell carcinoma	3	T3N0M0	IIIA	Malignant	*
H3	73	65	M	Bladder	Squamous cell carcinoma	3	T3bN0M0	IIIA	Malignant	6*4
H4	74	51	M	Bladder	Squamous cell carcinoma (sparse)	3	T4aN1M0	IIIA	Malignant	433
H5	75	60	M	Bladder	Adenocarcinoma	2	T2N1M0	IIIA	Malignant	*
H6	76	48	F	Bladder	Adenocarcinoma with degenerate	2	T3N0M0	IIIA	Malignant	1063
H7	77	70	M	Bladder	Adenocarcinoma	2	T3N0M0	IIIA	Malignant	*
H8	78	58	M	Bladder	Adenocarcinoma with necrosis	2	T3N1M0	IIIA	Malignant	*
H9	79	46	F	Bladder	Adenocarcinoma	2	T3bN2M0	IIIB	Malignant	*
H10	80	32	M	Bladder	Mucinous adenocarcinoma	2	T3N0M0	IIIA	Malignant	544
I1	81	76	M	Bladder	Adenocarcinoma	2--3	T4N0M0	IIIA	Malignant	*
I2	82	43	M	Bladder	Adenocarcinoma	3	T3aM0N0	IIIA	Malignant	1076
I3	83	65	M	Bladder	Adenocarcinoma	3	T3bN0M0	IIIA	Malignant	3*1.5
I4	84	50	M	Bladder	Adenocarcinoma	3	T3N0M0	IIIA	Malignant	652.5
I5	85	53	M	Bladder	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	*
I6	86	65	M	Bladder	Adenocarcinoma	3	T4N0M0	IIIA	Malignant	2.51.51
I7	87	53	F	Bladder	Mucinous adenocarcinoma	3	T3N0M0	IIIA	Malignant	*
I8	88	57	M	Bladder	Undifferentiated carcinoma	*	T2N1M0	IIIA	Malignant	*
I9	89	50	F	Bladder	Small cell carcinoma	*	T2N1M0	IIIA	Malignant	*
I10	90	49	F	Bladder	Small cell carcinoma	*	T3N1M0	IIIA	Malignant	*
_marker_

查找与该芯片存在重复病例的芯片:

如需了解产品规格方面的任何问题，请联系我们

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma